- Home
- PRAX vs ASIC Comparison
PRAX vs ASIC Comparison
Compare PRAX & ASIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- ASIC
- Stock Information
- Founded
- PRAX 2015
- ASIC 2018
- Country
- PRAX United States
- ASIC United States
- Employees
- PRAX N/A
- ASIC N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- ASIC Property-Casualty Insurers
- Sector
- PRAX Health Care
- ASIC Finance
- Exchange
- PRAX Nasdaq
- ASIC Nasdaq
- Market Cap
- PRAX 950.8M
- ASIC 1.1B
- IPO Year
- PRAX 2020
- ASIC 2025
- Fundamental
- Price
- PRAX $46.85
- ASIC $21.29
- Analyst Decision
- PRAX Strong Buy
- ASIC Strong Buy
- Analyst Count
- PRAX 9
- ASIC 4
- Target Price
- PRAX $94.44
- ASIC $27.00
- AVG Volume (30 Days)
- PRAX 388.4K
- ASIC 107.2K
- Earning Date
- PRAX 08-04-2025
- ASIC 08-11-2025
- Dividend Yield
- PRAX N/A
- ASIC N/A
- EPS Growth
- PRAX N/A
- ASIC N/A
- EPS
- PRAX N/A
- ASIC 0.15
- Revenue
- PRAX $7,765,000.00
- ASIC $378,302,000.00
- Revenue This Year
- PRAX N/A
- ASIC $16.14
- Revenue Next Year
- PRAX $25.00
- ASIC $47.06
- P/E Ratio
- PRAX N/A
- ASIC $142.94
- Revenue Growth
- PRAX 338.45
- ASIC 42.48
- 52 Week Low
- PRAX $26.70
- ASIC $18.50
- 52 Week High
- PRAX $91.83
- ASIC $25.30
- Technical
- Relative Strength Index (RSI)
- PRAX 47.63
- ASIC N/A
- Support Level
- PRAX $44.13
- ASIC N/A
- Resistance Level
- PRAX $47.06
- ASIC N/A
- Average True Range (ATR)
- PRAX 2.18
- ASIC 0.00
- MACD
- PRAX 0.05
- ASIC 0.00
- Stochastic Oscillator
- PRAX 54.73
- ASIC 0.00
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About ASIC Ategrity Specialty Insurance Company Holdings Common Stock
Ategrity Specialty Insurance Co Holdings Formerly Ategrity Specialty Holdings LLC is a specialty insurance company dedicated to providing excess and surplus products to small to medium-sized businesses across the United States. It offers property and casualty insurance solutions tailored to meet the needs of SMBs. The company focuses on are Real Estate, Hospitality, Construction, and Retail.